FDA Inspection 1120375 — Summit Surgical Corp.
The FDA completed an inspection of Summit Surgical Corp. on January 27, 2020 in Renton, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 27, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Renton, WA (United States)